959 related articles for article (PubMed ID: 20547248)
1. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
2. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
3. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
Lindfors K; Kaukinen K; Mäki M
Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in celiac disease.
Alaedini A; Green PH
Autoimmunity; 2008 Feb; 41(1):19-26. PubMed ID: 18176861
[TBL] [Abstract][Full Text] [Related]
5. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
[TBL] [Abstract][Full Text] [Related]
7. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
8. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease.
Koskinen O; Lindfors K; Collin P; Peräaho M; Laurila K; Woolley N; Partanen J; Mäki M; Kaukinen K
Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase in celiac disease: role of autoantibodies.
Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Rauhavirta T; Hietikko M; Salmi T; Lindfors K
Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 in celiac disease: minireview article.
Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
[TBL] [Abstract][Full Text] [Related]
14. Celiac disease: from gluten to autoimmunity.
Briani C; Samaroo D; Alaedini A
Autoimmun Rev; 2008 Sep; 7(8):644-50. PubMed ID: 18589004
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase--the key player in celiac disease: a review.
Reif S; Lerner A
Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
[TBL] [Abstract][Full Text] [Related]
16. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
Schuppan D; Dennis MD; Kelly CP
Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
[TBL] [Abstract][Full Text] [Related]
17. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
[TBL] [Abstract][Full Text] [Related]
18. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
19. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies and CD: past and future of celiac antibody testing.
Korponay-Szabó IR
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S11-3. PubMed ID: 24979192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]